Another knock for Otezla from the UK

[Fred]

Perhaps in the long term this may be a good strategy . If the companies can't sell their products where they want mainly because of price, perhaps they will have to rethink their pricing policies
England and Wales are not saying it doesn't work, it seems just that it is not cost effective. Perhaps if the cost were the same as methotrexate it may become cost effective

It'll never be the same as methotrexate Jim.

But they did get Stelara cheaper by holding off for psoriatic arthritis use.